💡SPOTLIGHT: Medical #research, which includes #clinicalresearch, is the invisible part of our health ecosystem that drives #innovation. Discover this and much more on CLINICAL TRIALS QUEBEC, powered by CATALIS in partnership with the government of Quebec: clinicaltrialsquebec.com/importance-cli…

Le Neuro est maintenant un pionnier de thérapie génique pour traiter la démence. Un patient atteint de Démence Frontotemporale (#DFT) a reçu une copie fonctionnelle du gène #GRN hier par vecteur virale - une première au Canada. buff.ly/4dinMkK Génome Québec Rémi Quirion

Dr. Simon Ducharme spoke to Andrew Carter CJAD yesterday about the 1st #genetherapy trial in Canada for #dementia. This landmark study for #FTD uses a viral vector to deliver a working copy of the #GRN gene to affected individuals. #theneuro omny.fm/shows/cjad-800…

Helen Fong (IA, MScA) a travaillé 20 ans comme infirmière clinicienne au @Neuro_MNI avant de se joindre à nous. «À l’URC, les infirmières jouent un double rôle : nous sommes à la fine pointe de la science, mais nous prenons également soin des gens.» #nationalnursingweek #mcgill

On International #HuntingtonsDisease Day, we celebrate advances in research for this hereditary, progressive neurological disorder. 8 studies are recruiting participants in Canada for this #raredisease, including 1 at the CRU in Montreal: cru.mcgill.ca/mvtdis. #mcgill #neuro

4th patient in the world to receive potential new #genetherapy treatment for #FTD with #GRN mutation was at The Neuro this month. Dr Simon Ducharme discussed the procedure on CBC News. This is the 1st gene therapy for #dementia in Canada. #mcgill cbc.ca/player/play/vi…

On #ClinicalTrialsDay, we celebrate our amazing team of #clinicalresearch coordinators: highly trained professionals who coordinate all aspects of study visits for 100+ trials. They'll tell you that working with our inspiring participants is the best part of the job. #icdt2024

During #MSAwarenessMonth, we highlight #MOGAD, a rare #demyelinating disease. A trial at The Neuro is evaluating whether an approved treatment for #NMOSD, a related condition, can reduce the inflammatory response in MOGAD better than the current SOC. cru.mcgill.ca/ms

🎉Congratulations to CRU nurse Helen Fong RN, MSc.A, selected among 30 nominees for the #DAISYAward from the #WFNN for her outstanding contribution to nursing. She was nominated by peers at The Neuro neurosurgery unit and CRU for her teaching and excellence in patient care.

Join us at the GBA1 meeting in Montreal, June 27-29th! Only a handful of tickets are left (more than 90% sold), and we are expecting a great meeting! Registration ends on June 12: give.michaeljfox.org/event/2024-gba…

New experimental arm for an innovative #glioblastoma trial now open at CRU! Investigational therapies are being studied in separate cohorts, increasing the potential treatments tested in a short time for this rapidly progressing brain tumor. cru.mcgill.ca/bt. #braintumor

CRU co-director Ziv Gan-Or and his Lab at The Neuro are working to accelerate #Parkinsons treatments. Using machine learning, they identified new genetic mutations and the inositol pathway as promising targets for drug development. Published in Brain: bit.ly/3Kyp2TL

A trial at the CRU is testing a new technique that hopes to shuttle large molecules (like #antibody treatments) across the blood-brain barrier to reach immune cells in the brain and better treat underlying inflammation between #MS relapses. #mcgill ➡️bit.ly/4bVgxOs

Des algorithmes d’#IA peuvent-ils être #sexistes/#racistes? Le #DétecteurDeRumeur sciencepresse #FRQ a identifié plusieurs exemples qui favorisent effectivement la discrimination! Kathleen Couillard Obvia RIQEDI DiPhus 🏳️‍🌈🇨🇦 IVADO CEIMiA ▶️ scientifique-en-chef.gouv.qc.ca/impact-recherc…

June is #MyastheniaGravis awareness month. This debilitating disease affects 10,000+ Canadians with loss of muscle function and rapid fatigue. The CRU is focussed on testing more precise #treatmentoptions to replace long-term immunosuppression. ➡️cru.mcgill.ca/nm #mcgill

CRU representation at #ENCALS2024 this week! Nisha Pulimood (r) presented a poster on darifenacin, a selective M3 muscarinic receptor antagonist, and its impact on #NMJ function in #ALS. HyungMo Kang's (c) poster outlined findings from Canadian biobanking initiative #CAPTUREALS.

According to the Brain Tumour Canada Foundation, Canada has one of the highest incidence of #glioblastoma in the world. Due to the complexity of these tumours, treatments remain elusive. That's why the CRU prioritizes studies into promising therapies. ➡️ cru.mcgill.ca/bt #mcgill

Ravis d'annoncer que #zilbrysq étudié à l'URC est approuvé par Santé Canada pour traiter la #myasthéniegrave! Des données publiées dans Lancet Neurology ont montré une amélioration significative en >12 semaines. L'auto-injection à domicile réduit le fardeau de cette #maladierare.

Healthy participants over 40 sought for #ParkinsonDisease #Biomarkers Study (#PDBS). Testing a new app to detect subtle changes in movement and help physicians assess and follow #PD disease progression more accurately. 1 month participation from home: cru.mcgill.ca/mvtdisorders.

#TheNeuro's 5th National Course on #SleepMedicine is a 2-day comprehensive program designed to enhance the knowledge + skills of #neurology residents (Royal College Exams prep), GPs and specialists. 📅 November 22-23, 2024 📋 Register: buff.ly/3S80THV #Mcgill #RCPS